This document discusses white blood cells (WBCs) and lymphoid tissues. It begins by introducing WBCs and their development stages. WBCs are categorized into granulocytes (neutrophils, eosinophils, basophils) and agranulocytes (lymphocytes, monocytes). The document then discusses specific WBC types in more detail, including their morphology, functions, and pathological variations seen in disorders. Disorders are categorized as non-neoplastic (increases or decreases in WBC counts) and neoplastic (leukemias and lymphomas). Overall, the document provides an overview of WBCs and lymphoid cells
White Blood Cell Disorders can affect neutrophils, eosinophils, basophils and mast cells. Neutropenia is classified by severity based on absolute neutrophil count and risk of infection. Causes include acquired conditions like drugs/infections or congenital disorders. Hypereosinophilic syndrome is a broad condition caused by primary or secondary eosinophilia leading to tissue damage. Diagnosis involves ruling out secondary causes and identifying organ involvement. Treatment depends on etiology and includes steroids, hydroxyurea, interferon-alpha, imatinib or anti-IL-5 antibodies.
This document discusses white blood cell disorders, focusing on quantitative disorders of the white blood cells. It describes leukocytosis, which is an increased number of white blood cells, and leukopenia, which is a decreased number. The main types of leukocytosis and leukopenia discussed are neutrophilic leukocytosis, lymphocytosis, and eosinophilia. The causes, pathophysiology, and clinical features of each of these conditions are explained in detail.
1. The document discusses several qualitative disorders of white blood cells including lazy leukocyte syndrome, Chediak-Higashi syndrome, infectious mononucleosis, leukemia, and lymphoma.
2. Key details are provided about the clinical features, oral manifestations, diagnosis, and management of each condition. Lazy leukocyte syndrome involves defects in neutrophil migration leading to recurrent infections. Chediak-Higashi syndrome is a genetic disorder characterized by enlarged granules and recurrent infections.
3. Infectious mononucleosis is caused by the Epstein-Barr virus and presents with fever, pharyngitis, adenopathy, and often oral lesions. Leukemia is classified as acute or chronic
This document discusses leukemoid and leukoerythroblastic reactions. Leukemoid reactions involve a marked increase in white blood cell count (>50,000/cumm) in response to a stimulus like infection, with immature cells comprising less than 5% and being reversible. Leukoerythroblastic reactions involve immature cells in both the red and white cell lines in peripheral blood due to bone marrow disturbances from conditions like cancer metastases or myelofibrosis. The document differentiates these reactions from conditions like CML, CNL, and CLL based on factors like age of onset, clinical course, blood and bone marrow morphology, and presence of an underlying condition.
1. The document discusses the differentiation between myeloid leukemoid reaction, chronic myeloid leukemia (CML), and chronic neutrophilic leukemia (CNL).
2. Key differences include peripheral smear findings, bone marrow aspirate/biopsy pictures, LAP scores, cytogenetics, and immunophenotyping results.
3. A leukemoid reaction is secondary to an underlying cause and shows features of that cause, while CML and CNL are myeloproliferative neoplasms with distinct clinical features, lab findings, and disease progression.
Platelet function tests.pptx 2.pptx finalAnupam Singh
This document summarizes platelet function testing. It discusses how platelets are formed from megakaryocytes in the bone marrow and circulate in the bloodstream. The major platelet function tests are platelet aggregometry, flow cytometry, and point-of-care tests like the impact cone and plate analyzer and thromboelastography. These tests are used to diagnose platelet disorders and monitor antiplatelet therapy. The document also briefly discusses platelet-derived microparticles and microRNAs, which can provide information about platelet activation and signaling.
This document provides an overview of white blood cell disorders, including common conditions such as neutropenia, lymphocytosis, leukemia, and lymphoma. It begins with an introduction to normal white blood cell production and classification. Key points covered include the clinical features and pathogenesis of various leukopenias and leukocytoses. Classification systems for hematologic neoplasms such as leukemia subtypes (AML, ALL, CML, CLL) and lymphomas (Hodgkins, Non-Hodgkins) are summarized. Premalignant conditions like myeloproliferative disorders and myelodysplastic syndromes are also briefly outlined.
Haemolysis indicates that there is shortening of the normal red cell lifespan of 120 days. There are many causes.
To compensate, the bone marrow may increase its output of red cells six- to eightfold by increasing the proportion of red cells produced, expanding the volume of active marrow, and releasing reticulocytes prematurely. Anaemia occurs only if the rate of destruction exceeds this increased production rate.
White Blood Cell Disorders can affect neutrophils, eosinophils, basophils and mast cells. Neutropenia is classified by severity based on absolute neutrophil count and risk of infection. Causes include acquired conditions like drugs/infections or congenital disorders. Hypereosinophilic syndrome is a broad condition caused by primary or secondary eosinophilia leading to tissue damage. Diagnosis involves ruling out secondary causes and identifying organ involvement. Treatment depends on etiology and includes steroids, hydroxyurea, interferon-alpha, imatinib or anti-IL-5 antibodies.
This document discusses white blood cell disorders, focusing on quantitative disorders of the white blood cells. It describes leukocytosis, which is an increased number of white blood cells, and leukopenia, which is a decreased number. The main types of leukocytosis and leukopenia discussed are neutrophilic leukocytosis, lymphocytosis, and eosinophilia. The causes, pathophysiology, and clinical features of each of these conditions are explained in detail.
1. The document discusses several qualitative disorders of white blood cells including lazy leukocyte syndrome, Chediak-Higashi syndrome, infectious mononucleosis, leukemia, and lymphoma.
2. Key details are provided about the clinical features, oral manifestations, diagnosis, and management of each condition. Lazy leukocyte syndrome involves defects in neutrophil migration leading to recurrent infections. Chediak-Higashi syndrome is a genetic disorder characterized by enlarged granules and recurrent infections.
3. Infectious mononucleosis is caused by the Epstein-Barr virus and presents with fever, pharyngitis, adenopathy, and often oral lesions. Leukemia is classified as acute or chronic
This document discusses leukemoid and leukoerythroblastic reactions. Leukemoid reactions involve a marked increase in white blood cell count (>50,000/cumm) in response to a stimulus like infection, with immature cells comprising less than 5% and being reversible. Leukoerythroblastic reactions involve immature cells in both the red and white cell lines in peripheral blood due to bone marrow disturbances from conditions like cancer metastases or myelofibrosis. The document differentiates these reactions from conditions like CML, CNL, and CLL based on factors like age of onset, clinical course, blood and bone marrow morphology, and presence of an underlying condition.
1. The document discusses the differentiation between myeloid leukemoid reaction, chronic myeloid leukemia (CML), and chronic neutrophilic leukemia (CNL).
2. Key differences include peripheral smear findings, bone marrow aspirate/biopsy pictures, LAP scores, cytogenetics, and immunophenotyping results.
3. A leukemoid reaction is secondary to an underlying cause and shows features of that cause, while CML and CNL are myeloproliferative neoplasms with distinct clinical features, lab findings, and disease progression.
Platelet function tests.pptx 2.pptx finalAnupam Singh
This document summarizes platelet function testing. It discusses how platelets are formed from megakaryocytes in the bone marrow and circulate in the bloodstream. The major platelet function tests are platelet aggregometry, flow cytometry, and point-of-care tests like the impact cone and plate analyzer and thromboelastography. These tests are used to diagnose platelet disorders and monitor antiplatelet therapy. The document also briefly discusses platelet-derived microparticles and microRNAs, which can provide information about platelet activation and signaling.
This document provides an overview of white blood cell disorders, including common conditions such as neutropenia, lymphocytosis, leukemia, and lymphoma. It begins with an introduction to normal white blood cell production and classification. Key points covered include the clinical features and pathogenesis of various leukopenias and leukocytoses. Classification systems for hematologic neoplasms such as leukemia subtypes (AML, ALL, CML, CLL) and lymphomas (Hodgkins, Non-Hodgkins) are summarized. Premalignant conditions like myeloproliferative disorders and myelodysplastic syndromes are also briefly outlined.
Haemolysis indicates that there is shortening of the normal red cell lifespan of 120 days. There are many causes.
To compensate, the bone marrow may increase its output of red cells six- to eightfold by increasing the proportion of red cells produced, expanding the volume of active marrow, and releasing reticulocytes prematurely. Anaemia occurs only if the rate of destruction exceeds this increased production rate.
Leukemias are malignant diseases of the bone marrow characterized by the abnormal proliferation of white blood cells. The document discusses the classification, pathogenesis, epidemiology, clinical features, diagnosis and prognosis of various types of leukemias. It describes the key subtypes of acute and chronic leukemias, focusing on chronic myeloid leukemia, which results from a genetic translocation forming the Philadelphia chromosome and the constitutively active BCR-ABL fusion oncogene that drives uncontrolled myeloid cell growth.
This document summarizes the morphology of normal white blood cells and platelets. It provides reference ranges for total white blood cell count and differential counts. It describes the characteristics of neutrophils, eosinophils, basophils, lymphocytes, and monocytes. It also discusses qualitative abnormalities that may affect white blood cells, including inherited conditions, acquired conditions, and leukemias. Finally, it provides a brief overview of platelet structure and disorders of platelets.
This document summarizes quantitative and qualitative platelet disorders. The most common causes of abnormal bleeding are decreased platelet production, survival, or increased destruction/consumption. Disorders can be congenital or acquired and involve decreased megakaryocyte production, BM infiltration, ineffective thrombopoiesis, or disorders of thrombopoiesis control. Increased platelet destruction can be immunologic due to ITP, drugs, transfusion, or non-immunologic consumption. Functional platelet disorders involve adhesion, aggregation, or secretion defects which may be hereditary or acquired.
Overview to Diagnosis of Acute leukemiaAhmed Makboul
Acute leukemia can be classified based on aggressiveness, lineage, and site of involvement. Diagnosis requires morphology identification of blasts, cytochemistry including MPO and esterase staining, immunophenotyping by flow cytometry, and genetic studies like cytogenetics and molecular genetics. Cytogenetics identifies prognostic groups in AML and distinguishes secondary from de novo disease. Molecular genetics detects cryptic abnormalities and monitors minimal residual disease. Together, these analyses classify acute leukemias and guide treatment decisions.
The document provides information about peripheral blood smear examination. It discusses how peripheral blood smears are an important diagnostic tool that provide information about hematologic disorders through examination of red blood cells, white blood cells, and platelets. It outlines the procedure for preparing, staining, and examining a peripheral blood smear under the microscope. Key things examined include red blood cell size, shape, color, and inclusions, as well as white blood cell and platelet counts, differentials, and morphologies. Common red blood cell abnormalities seen include microcytosis, macrocytosis, anisocytosis, poikilocytosis, hypochromasia, polychromasia, and inclusions.
Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy. It is characterized by the proliferation of lymphoblasts in the bone marrow. ALL is classified into subtypes based on morphology, immunophenotyping and genetics. The disease is associated with genetic conditions and environmental exposures. Prognosis depends on factors like age, white blood cell count, cytogenetics and response to treatment. Immunophenotyping and detection of minimal residual disease help diagnosis and monitoring of ALL.
This document describes normal red blood cell morphology and various abnormalities that can occur. A normal red blood cell is biconcave and disk-like in shape, containing hemoglobin and lacking a nucleus. Abnormalities include variations in size (anisocytosis), shape (poikilocytosis), and inclusions within red blood cells. Specific abnormal RBC shapes discussed include spherocytes, ovalocytes, burr cells, crenated cells, schistocytes, and sickle cells. Causes of these abnormalities and other findings like basophilic stippling are also summarized.
Hemolytic anemia is characterized by accelerated red blood cell destruction and vigorous blood regeneration. It can be classified as intrinsic or extrinsic, congenital or acquired. The site of red blood cell destruction can be intravascular or extravascular. Common causes of hemolytic anemia include hereditary spherocytosis, thalassemias, sickle cell anemia, glucose-6-phosphate dehydrogenase deficiency, paroxysmal nocturnal hemoglobinuria, and immune-mediated hemolytic anemia. Evaluation of hemolytic anemia involves determining whether the anemia is hemolytic, the site of red blood cell destruction, the etiology, and severity through blood smears, reticulocyte counts, LDH and
Sickle cell anemia is caused by a genetic mutation that results in abnormal hemoglobin called HbS. When HbS is deoxygenated, it polymerizes inside red blood cells, causing them to take on a sickle or holly leaf shape. This leads to hemolysis, anemia, vaso-occlusive crises involving painful blockages in small blood vessels, and organ damage. The condition is most common where malaria is endemic, as the sickle cell trait provides resistance to that disease. Laboratory testing can demonstrate sickle cells on blood smears and the presence of HbS on electrophoresis.
Fluid cytology in serous cavity effusionstashagarwal
The intrathoracic and intraperitoneal organs are covered by a single layer of mesothelial cells, which is continuous with the lining of the thoracic and peritoneal cavities. The potential space between the two layers of epithelium contains a small amount of lubricating fluid.
Serous fluid lies between the membranes lining the body cavities(parietal) and those covering the organs within the cavities(visceral).
Production and reabsorption are normally at a constant rate. They are influenced by
Changes in osmotic and hydrostatic pressure in the blood.
Concentration of chemical constituents in the plasma
Permeability of blood vessels and membranes.
An accumulation of fluid, called an effusion, results from an imbalance of fluid production and reabsorption. This fluid accumulation in the pleural, pericardial, and peritoneal cavities is known as serous effusion.
Leukocytosis is an increased white blood cell count in the blood. There are five main types: neutrophilia, lymphocytosis, monocytosis, eosinophilia, and basophilia. Neutrophilia is most common and usually due to bacterial infection. Eosinophilia can be caused by allergic disorders, parasites, and some cancers. Lymphocytosis is seen with viral infections and lymphomas. Leukopenia and neutropenia involve decreased white blood cell and neutrophil counts respectively, increasing infection risk. Lymphoma involves abnormal lymphocyte proliferation. Leukemia includes acute and chronic forms, with acute being more aggressive and involving immature cells.
This presentation is focused on diagnostic utility of Red blood cell indices which will be very useful for undergraduate and postgraduate of medical field.
This document discusses several red blood cell indices used to characterize anemias, including mean cell volume (MCV), mean cell hemoglobin (MCH), mean cell hemoglobin concentration (MCHC), and red cell distribution width (RDW). It provides details on how each index is calculated and interpreted, and examples of abnormal red blood cell morphologies seen in different types of anemias that would affect the index values.
The document discusses abnormalities of white blood cells, including quantitative abnormalities like leukocytosis and leukopenia as well as qualitative abnormalities involving the nucleus or cytoplasm of white blood cells. Some examples of qualitative abnormalities discussed include Pelger-Huet anomaly, Chediak-Steinbrinck-Higashi syndrome, and Auer rods. The types of white blood cells are described along with causes of conditions like neutrophilia, eosinophilia, lymphocytosis, and monocytosis. Inherited and acquired morphological and functional abnormalities of white blood cells are also summarized.
This document discusses peroxidase staining, which is used to differentiate between myelogenous or monocytic leukemia and acute lymphocytic leukemia. Peroxidase is present in the primary granules of neutrophils, eosinophils, and monocytes, and activity increases with maturation. The peroxidase stain principle involves myeloperoxidase catalyzing hydrogen peroxide to oxidize a substrate like benzidine or DAB, forming a black precipitate. A peroxidase stain will show red-brown staining in neutrophils, eosinophils in promyelocyte through metamyelocyte stages, and finely granular staining in monocytes.
This document provides information on various cytochemical staining techniques used in hematology, including myeloperoxidase, esterase, alkaline phosphatase, acid phosphatase, Sudan black B, periodic acid Schiff, and Toluidine blue staining. It describes the principle, reagents, procedure, and interpretation for each stain. These stains are used to classify and diagnose different types of leukemia by identifying cellular enzymes and components in blood and bone marrow samples.
Chronic leukemia is a type of cancer that results in the overproduction of white blood cells. There are two main types: chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML). CLL involves an overgrowth of B lymphocytes, while CML affects granulocytes. Symptoms include fatigue, enlarged lymph nodes or spleen. Treatment involves chemotherapy, monoclonal antibodies, radiation therapy, or bone marrow transplantation depending on the type and stage of leukemia. Newer targeted therapies such as tyrosine kinase inhibitors have improved treatment of CML.
Hemolytic anemias are caused by increased red blood cell destruction. They are characterized by normochromic, normocytic anemia with reticulocytosis, increased indirect bilirubin and LDH, and absent haptoglobin. Causes include membrane defects, metabolic abnormalities, hemoglobinopathies, and immune or non-immune mechanisms. Specific conditions discussed include hereditary spherocytosis, glucose-6-phosphate dehydrogenase deficiency, paroxysmal nocturnal hemoglobinuria, drug-induced hemolysis, alloimmune hemolytic anemia, and warm or cold autoimmune hemolytic anemia. Management depends on the underlying cause and may involve transfusions, medications, or splenectomy.
This document provides a classification and overview of hemolytic anemia. It discusses intracorpuscular defects like hereditary membrane defects (spherocytosis, elliptocytosis), enzyme defects (G6PD, pyruvate kinase), and hemoglobinopathies. Extracorpuscular defects include immune hemolytic anemia (autoimmune, alloimmune) and nonimmune causes. Evaluation of anemia involves hematological parameters. Thalassemias are classified based on affected globin chain (alpha, beta). Common hereditary spherocytosis causes premature RBC destruction and can be treated with splenectomy. G6PD deficiency results in drug-induced hemolysis.
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hematopoietic stem cell disorder characterized by hemolytic anemia. It arises due to a somatic mutation in the PIGA gene, causing deficiency of glycosylphosphatidylinositol-anchored proteins (GPI-APs) like CD55 and CD59 on the surface of blood cells. This renders the cells highly sensitive to complement-mediated lysis. Diagnosis involves flow cytometry to detect GPI-AP deficiency and tests like Ham and sucrose hemolysis to demonstrate complement sensitivity of the red blood cells. PNH is associated with hemoglobinuria, thrombosis, and bone marrow failure. It requires differentiation
This document provides information on white blood cell disorders, including qualitative and quantitative disorders. It discusses Chediak-Higashi syndrome, a rare autosomal recessive disorder characterized by abnormal granules in neutrophils resulting in decreased immune function. Leukemia is summarized as a malignant disorder of stem cells associated with increased white cells in bone marrow and blood. The classification, clinical features, investigations and management of acute leukemia are outlined.
1. White blood cells (leukocytes) include granulocytes like neutrophils, eosinophils, and basophils which fight infection, and agranulocytes like monocytes and lymphocytes which are involved in immune responses.
2. Leukemia is a cancer of the blood cells characterized by abnormal proliferation of white blood cells. The four main types are acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, and chronic lymphocytic leukemia.
3. Factors involved in leukemia development include genetic mutations, chromosomal translocations, radiation exposure, certain chemicals, and some viruses. Maintaining overall health can help support white blood cell counts.
Leukemias are malignant diseases of the bone marrow characterized by the abnormal proliferation of white blood cells. The document discusses the classification, pathogenesis, epidemiology, clinical features, diagnosis and prognosis of various types of leukemias. It describes the key subtypes of acute and chronic leukemias, focusing on chronic myeloid leukemia, which results from a genetic translocation forming the Philadelphia chromosome and the constitutively active BCR-ABL fusion oncogene that drives uncontrolled myeloid cell growth.
This document summarizes the morphology of normal white blood cells and platelets. It provides reference ranges for total white blood cell count and differential counts. It describes the characteristics of neutrophils, eosinophils, basophils, lymphocytes, and monocytes. It also discusses qualitative abnormalities that may affect white blood cells, including inherited conditions, acquired conditions, and leukemias. Finally, it provides a brief overview of platelet structure and disorders of platelets.
This document summarizes quantitative and qualitative platelet disorders. The most common causes of abnormal bleeding are decreased platelet production, survival, or increased destruction/consumption. Disorders can be congenital or acquired and involve decreased megakaryocyte production, BM infiltration, ineffective thrombopoiesis, or disorders of thrombopoiesis control. Increased platelet destruction can be immunologic due to ITP, drugs, transfusion, or non-immunologic consumption. Functional platelet disorders involve adhesion, aggregation, or secretion defects which may be hereditary or acquired.
Overview to Diagnosis of Acute leukemiaAhmed Makboul
Acute leukemia can be classified based on aggressiveness, lineage, and site of involvement. Diagnosis requires morphology identification of blasts, cytochemistry including MPO and esterase staining, immunophenotyping by flow cytometry, and genetic studies like cytogenetics and molecular genetics. Cytogenetics identifies prognostic groups in AML and distinguishes secondary from de novo disease. Molecular genetics detects cryptic abnormalities and monitors minimal residual disease. Together, these analyses classify acute leukemias and guide treatment decisions.
The document provides information about peripheral blood smear examination. It discusses how peripheral blood smears are an important diagnostic tool that provide information about hematologic disorders through examination of red blood cells, white blood cells, and platelets. It outlines the procedure for preparing, staining, and examining a peripheral blood smear under the microscope. Key things examined include red blood cell size, shape, color, and inclusions, as well as white blood cell and platelet counts, differentials, and morphologies. Common red blood cell abnormalities seen include microcytosis, macrocytosis, anisocytosis, poikilocytosis, hypochromasia, polychromasia, and inclusions.
Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy. It is characterized by the proliferation of lymphoblasts in the bone marrow. ALL is classified into subtypes based on morphology, immunophenotyping and genetics. The disease is associated with genetic conditions and environmental exposures. Prognosis depends on factors like age, white blood cell count, cytogenetics and response to treatment. Immunophenotyping and detection of minimal residual disease help diagnosis and monitoring of ALL.
This document describes normal red blood cell morphology and various abnormalities that can occur. A normal red blood cell is biconcave and disk-like in shape, containing hemoglobin and lacking a nucleus. Abnormalities include variations in size (anisocytosis), shape (poikilocytosis), and inclusions within red blood cells. Specific abnormal RBC shapes discussed include spherocytes, ovalocytes, burr cells, crenated cells, schistocytes, and sickle cells. Causes of these abnormalities and other findings like basophilic stippling are also summarized.
Hemolytic anemia is characterized by accelerated red blood cell destruction and vigorous blood regeneration. It can be classified as intrinsic or extrinsic, congenital or acquired. The site of red blood cell destruction can be intravascular or extravascular. Common causes of hemolytic anemia include hereditary spherocytosis, thalassemias, sickle cell anemia, glucose-6-phosphate dehydrogenase deficiency, paroxysmal nocturnal hemoglobinuria, and immune-mediated hemolytic anemia. Evaluation of hemolytic anemia involves determining whether the anemia is hemolytic, the site of red blood cell destruction, the etiology, and severity through blood smears, reticulocyte counts, LDH and
Sickle cell anemia is caused by a genetic mutation that results in abnormal hemoglobin called HbS. When HbS is deoxygenated, it polymerizes inside red blood cells, causing them to take on a sickle or holly leaf shape. This leads to hemolysis, anemia, vaso-occlusive crises involving painful blockages in small blood vessels, and organ damage. The condition is most common where malaria is endemic, as the sickle cell trait provides resistance to that disease. Laboratory testing can demonstrate sickle cells on blood smears and the presence of HbS on electrophoresis.
Fluid cytology in serous cavity effusionstashagarwal
The intrathoracic and intraperitoneal organs are covered by a single layer of mesothelial cells, which is continuous with the lining of the thoracic and peritoneal cavities. The potential space between the two layers of epithelium contains a small amount of lubricating fluid.
Serous fluid lies between the membranes lining the body cavities(parietal) and those covering the organs within the cavities(visceral).
Production and reabsorption are normally at a constant rate. They are influenced by
Changes in osmotic and hydrostatic pressure in the blood.
Concentration of chemical constituents in the plasma
Permeability of blood vessels and membranes.
An accumulation of fluid, called an effusion, results from an imbalance of fluid production and reabsorption. This fluid accumulation in the pleural, pericardial, and peritoneal cavities is known as serous effusion.
Leukocytosis is an increased white blood cell count in the blood. There are five main types: neutrophilia, lymphocytosis, monocytosis, eosinophilia, and basophilia. Neutrophilia is most common and usually due to bacterial infection. Eosinophilia can be caused by allergic disorders, parasites, and some cancers. Lymphocytosis is seen with viral infections and lymphomas. Leukopenia and neutropenia involve decreased white blood cell and neutrophil counts respectively, increasing infection risk. Lymphoma involves abnormal lymphocyte proliferation. Leukemia includes acute and chronic forms, with acute being more aggressive and involving immature cells.
This presentation is focused on diagnostic utility of Red blood cell indices which will be very useful for undergraduate and postgraduate of medical field.
This document discusses several red blood cell indices used to characterize anemias, including mean cell volume (MCV), mean cell hemoglobin (MCH), mean cell hemoglobin concentration (MCHC), and red cell distribution width (RDW). It provides details on how each index is calculated and interpreted, and examples of abnormal red blood cell morphologies seen in different types of anemias that would affect the index values.
The document discusses abnormalities of white blood cells, including quantitative abnormalities like leukocytosis and leukopenia as well as qualitative abnormalities involving the nucleus or cytoplasm of white blood cells. Some examples of qualitative abnormalities discussed include Pelger-Huet anomaly, Chediak-Steinbrinck-Higashi syndrome, and Auer rods. The types of white blood cells are described along with causes of conditions like neutrophilia, eosinophilia, lymphocytosis, and monocytosis. Inherited and acquired morphological and functional abnormalities of white blood cells are also summarized.
This document discusses peroxidase staining, which is used to differentiate between myelogenous or monocytic leukemia and acute lymphocytic leukemia. Peroxidase is present in the primary granules of neutrophils, eosinophils, and monocytes, and activity increases with maturation. The peroxidase stain principle involves myeloperoxidase catalyzing hydrogen peroxide to oxidize a substrate like benzidine or DAB, forming a black precipitate. A peroxidase stain will show red-brown staining in neutrophils, eosinophils in promyelocyte through metamyelocyte stages, and finely granular staining in monocytes.
This document provides information on various cytochemical staining techniques used in hematology, including myeloperoxidase, esterase, alkaline phosphatase, acid phosphatase, Sudan black B, periodic acid Schiff, and Toluidine blue staining. It describes the principle, reagents, procedure, and interpretation for each stain. These stains are used to classify and diagnose different types of leukemia by identifying cellular enzymes and components in blood and bone marrow samples.
Chronic leukemia is a type of cancer that results in the overproduction of white blood cells. There are two main types: chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML). CLL involves an overgrowth of B lymphocytes, while CML affects granulocytes. Symptoms include fatigue, enlarged lymph nodes or spleen. Treatment involves chemotherapy, monoclonal antibodies, radiation therapy, or bone marrow transplantation depending on the type and stage of leukemia. Newer targeted therapies such as tyrosine kinase inhibitors have improved treatment of CML.
Hemolytic anemias are caused by increased red blood cell destruction. They are characterized by normochromic, normocytic anemia with reticulocytosis, increased indirect bilirubin and LDH, and absent haptoglobin. Causes include membrane defects, metabolic abnormalities, hemoglobinopathies, and immune or non-immune mechanisms. Specific conditions discussed include hereditary spherocytosis, glucose-6-phosphate dehydrogenase deficiency, paroxysmal nocturnal hemoglobinuria, drug-induced hemolysis, alloimmune hemolytic anemia, and warm or cold autoimmune hemolytic anemia. Management depends on the underlying cause and may involve transfusions, medications, or splenectomy.
This document provides a classification and overview of hemolytic anemia. It discusses intracorpuscular defects like hereditary membrane defects (spherocytosis, elliptocytosis), enzyme defects (G6PD, pyruvate kinase), and hemoglobinopathies. Extracorpuscular defects include immune hemolytic anemia (autoimmune, alloimmune) and nonimmune causes. Evaluation of anemia involves hematological parameters. Thalassemias are classified based on affected globin chain (alpha, beta). Common hereditary spherocytosis causes premature RBC destruction and can be treated with splenectomy. G6PD deficiency results in drug-induced hemolysis.
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hematopoietic stem cell disorder characterized by hemolytic anemia. It arises due to a somatic mutation in the PIGA gene, causing deficiency of glycosylphosphatidylinositol-anchored proteins (GPI-APs) like CD55 and CD59 on the surface of blood cells. This renders the cells highly sensitive to complement-mediated lysis. Diagnosis involves flow cytometry to detect GPI-AP deficiency and tests like Ham and sucrose hemolysis to demonstrate complement sensitivity of the red blood cells. PNH is associated with hemoglobinuria, thrombosis, and bone marrow failure. It requires differentiation
This document provides information on white blood cell disorders, including qualitative and quantitative disorders. It discusses Chediak-Higashi syndrome, a rare autosomal recessive disorder characterized by abnormal granules in neutrophils resulting in decreased immune function. Leukemia is summarized as a malignant disorder of stem cells associated with increased white cells in bone marrow and blood. The classification, clinical features, investigations and management of acute leukemia are outlined.
1. White blood cells (leukocytes) include granulocytes like neutrophils, eosinophils, and basophils which fight infection, and agranulocytes like monocytes and lymphocytes which are involved in immune responses.
2. Leukemia is a cancer of the blood cells characterized by abnormal proliferation of white blood cells. The four main types are acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, and chronic lymphocytic leukemia.
3. Factors involved in leukemia development include genetic mutations, chromosomal translocations, radiation exposure, certain chemicals, and some viruses. Maintaining overall health can help support white blood cell counts.
This document summarizes the morphology of normal white blood cells and some abnormalities. It describes the main types of granulocytes (neutrophils, eosinophils, basophils) and their characteristics. It also discusses monocytes/macrophages and lymphocytes. Causes of conditions like leukocytosis, neutrophilia, lymphocytosis, and eosinophilia are provided. Some morphological abnormalities of white blood cells like toxic granulation and Pelger-Huet anomaly are also summarized.
Causes of Leukocytosis, Leokopenia, Lymphocytosis and Leukemoid reactions..pptxUtkarsh Sharma
This document summarizes various disorders of white blood cells, including leukocytosis, leukopenia, lymphocytosis, and leukemoid reactions. It describes the causes and characteristics of these conditions. Proliferative disorders can be reactive or neoplastic. Leukopenia is usually caused by neutropenia and results from reduced bone marrow production or increased destruction of neutrophils. Agranulocytosis is a severe form of neutropenia caused by drugs or idiosyncratic reactions. Leukocytosis can result from infections, inflammation, burns, or metastatic cancer stimulating bone marrow. Leukemoid reactions involve markedly elevated white counts with immature cells resembling leukemia but occurring in non-leukemic disorders.
complete information about the cancer condition that is leukemia - introduction, definition, etiology and causes, pathophysiology ,types, clinical manifestations, diagnosis, nursing management, medical management, nursing research .
This document provides an overview of leukemia, including its definition, types, causes, symptoms, diagnosis, and treatment. Leukemia is a cancer of the blood and bone marrow characterized by abnormal blood cell production. There are four main types classified by cell type and disease progression: acute or chronic, myeloid or lymphoid. Causes are often genetic defects or environmental exposures. Symptoms vary by type but can include fatigue, infections, bruising, and organ enlargement. Diagnosis involves blood and bone marrow tests. Treatment aims to cure or control the disease using chemotherapy, radiation, stem cell transplants, and supportive care.
This document discusses several non-neoplastic and neoplastic disorders of white blood cells. It describes leukopenia, neutropenia, agranulocytosis, and reactive leukocytosis as non-neoplastic disorders. It then summarizes several types of lymphoid neoplasms including acute lymphoblastic leukemia/lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, and follicular lymphoma. Key features such as pathogenesis, clinical presentation, and distinguishing characteristics are highlighted for each condition.
This document provides an overview of leukemias, including:
- Leukemia is a cancer of the blood and bone marrow that results in an overproduction of immature white blood cells.
- There are four main types: acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia.
- Signs and symptoms vary depending on the type but can include fatigue, infections, anemia, bruising/bleeding, and enlargement of the liver and spleen.
- Diagnosis involves blood tests, bone marrow biopsy, and other exams. Treatment involves chemotherapy, targeted therapies, radiation, stem cell transplant, and management of symptoms.
Leukopenia is an abnormal reduction in white blood cells. It can result from reduced white blood cell production or increased destruction. The main types of white blood cells are neutrophils, lymphocytes, basophils, monocytes, and eosinophils, which help fight different types of infections. Kostmann syndrome is a rare, congenital neutropenia disorder characterized by lack of mature neutrophils and recurrent bacterial infections. Growth factor therapy increases neutrophil production and aids the body's natural healing process.
Multiple myeloma is a cancer of plasma cells that proliferate in the bone marrow. It accounts for 10% of hematological cancers and typically affects older adults. The cancerous plasma cells secrete abnormal antibodies that can cause anemia, kidney damage, bone lesions, and immunosuppression. Symptoms may include bone pain, fatigue, recurrent infections. Diagnosis involves blood and urine tests detecting the abnormal antibodies and reduced blood counts. Treatment options include chemotherapy, steroids, stem cell transplantation, and newer targeted therapies to control the cancer and complications.
This document discusses common childhood cancers, focusing on leukemias. It provides details on the types and subtypes of leukemia, risk factors, clinical presentation, evaluation, and management. The main types discussed are acute lymphoblastic leukemia (ALL), which is the most common childhood cancer, and acute myeloid leukemia (AML). The management of ALL involves induction therapy to achieve remission, CNS prophylaxis to prevent spread to the brain, intensification therapy, and maintenance therapy to prevent relapse.
Hematology Granulopoiesis White blood cell production222101989
This document provides an overview of granulopoiesis, the formation of white blood cells from stem cells in the bone marrow. It discusses the myeloid maturation sequence, from myeloblasts to segmented granulocytes. The functions of granulocytes like neutrophils, eosinophils and basophils are described, including chemotaxis, phagocytosis, and killing of microbes. The document also summarizes lymphocyte development and the causes of increased or decreased white blood cell counts. Finally, it reviews some morphological abnormalities seen in neutrophils.
references
20th edition of Harrison's T.B. OF INTERNAL MEDICINE
Blood and Lymphatic Cancer: Targets and Therapy
Advances in the diagnosis and management
of lymphoma
Zachary H Word1
Matthew J Matasar1,2
This document discusses aplastic anemia, a bone marrow failure syndrome characterized by pancytopenia. It defines aplastic anemia as a failure of the bone marrow to produce sufficient blood cells, resulting in low red blood cells, white blood cells, and platelets. The causes include stem cell defects, bone marrow suppression by drugs or radiation, bone marrow infiltration by cancer cells, and immune-mediated destruction of hematopoietic stem cells. Aplastic anemia is evaluated based on symptoms of anemia, bleeding, and infections, along with low blood counts and a hypoplastic bone marrow on biopsy with less than 25% cellularity.
This document summarizes pathology related to white blood cells. It discusses non-neoplastic disorders like leukopenia (decreased white blood cells), neutropenia (decreased neutrophils), and reactive leukocytosis (increased white blood cells in response to infection). It also discusses neoplastic disorders of white blood cells. Specifically, it provides details on infectious mononucleosis caused by Epstein-Barr virus, including pathogenesis, morphology, and clinical features like fever, sore throat, and lymphadenitis. It also discusses cyclic neutropenia, a rare condition where neutrophil counts decrease periodically.
This document discusses leukemias and provides information about leukemoid reactions. It defines a leukemoid reaction as a high white blood cell count with neutrophilia usually in response to infection, which can mimic chronic myelogenous leukemia or acute myeloid leukemia. The document notes that serum leukocyte alkaline phosphatase is normally elevated in leukemoid reactions, distinguishing it from CML where it is depressed. Features suggesting a leukemoid reaction rather than leukemia include toxic granulation, a high LAP score, and an obvious cause of the neutrophilia such as infection. The document provides several potential causes of leukemoid reactions and discusses methods for distinguishing leukemoid reactions from leukemia.
This document discusses different types of hypersensitivity reactions. Type II hypersensitivity involves autoantibodies that stimulate host target cell receptors, causing issues like autoimmune hemolytic anemia or Graves' disease. Type III hypersensitivity involves immune complex deposition that can cause conditions like Raynaud's phenomenon or membranous glomerulonephritis. Type IV delayed hypersensitivity involves T cell-mediated responses to environmental antigens, commonly causing contact dermatitis.
This document discusses leukocyte disorders and provides information about acute leukemia. It defines leukocytosis and leukopenia as increases or decreases in white blood cell count. Non-neoplastic causes of changes in white blood cells include neutrophilia, lymphocytosis, eosinophilia, monocytosis, and basophilia. Neoplastic disorders include acute myeloid leukemia and acute lymphoblastic leukemia. The document outlines the classification, pathogenesis, clinical features, diagnosis and treatment of acute leukemias. Diagnosis involves examination of blood and bone marrow smears, cytochemistry, immunophenotyping, cytogenetics and molecular analysis to determine the leukemia subtype and guide treatment.
The technology uses reclaimed CO₂ as the dyeing medium in a closed loop process. When pressurized, CO₂ becomes supercritical (SC-CO₂). In this state CO₂ has a very high solvent power, allowing the dye to dissolve easily.
The binding of cosmological structures by massless topological defectsSérgio Sacani
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills MN
Travis Hills of Minnesota developed a method to convert waste into high-value dry fertilizer, significantly enriching soil quality. By providing farmers with a valuable resource derived from waste, Travis Hills helps enhance farm profitability while promoting environmental stewardship. Travis Hills' sustainable practices lead to cost savings and increased revenue for farmers by improving resource efficiency and reducing waste.
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...Sérgio Sacani
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
hematic appreciation test is a psychological assessment tool used to measure an individual's appreciation and understanding of specific themes or topics. This test helps to evaluate an individual's ability to connect different ideas and concepts within a given theme, as well as their overall comprehension and interpretation skills. The results of the test can provide valuable insights into an individual's cognitive abilities, creativity, and critical thinking skills
ESPP presentation to EU Waste Water Network, 4th June 2024 “EU policies driving nutrient removal and recycling
and the revised UWWTD (Urban Waste Water Treatment Directive)”
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...Leonel Morgado
Current descriptions of immersive learning cases are often difficult or impossible to compare. This is due to a myriad of different options on what details to include, which aspects are relevant, and on the descriptive approaches employed. Also, these aspects often combine very specific details with more general guidelines or indicate intents and rationales without clarifying their implementation. In this paper we provide a method to describe immersive learning cases that is structured to enable comparisons, yet flexible enough to allow researchers and practitioners to decide which aspects to include. This method leverages a taxonomy that classifies educational aspects at three levels (uses, practices, and strategies) and then utilizes two frameworks, the Immersive Learning Brain and the Immersion Cube, to enable a structured description and interpretation of immersive learning cases. The method is then demonstrated on a published immersive learning case on training for wind turbine maintenance using virtual reality. Applying the method results in a structured artifact, the Immersive Learning Case Sheet, that tags the case with its proximal uses, practices, and strategies, and refines the free text case description to ensure that matching details are included. This contribution is thus a case description method in support of future comparative research of immersive learning cases. We then discuss how the resulting description and interpretation can be leveraged to change immersion learning cases, by enriching them (considering low-effort changes or additions) or innovating (exploring more challenging avenues of transformation). The method holds significant promise to support better-grounded research in immersive learning.
1. Disorders of White Blood Cells
and Lymphoid Tissues
BY: MRS. GARIMA NAGPAL
Tutor, Pathology
MMU, MULLANA
2. objective
1. Introduction of white blood cells and lymphoid cells.
2. Development satges of wbcs and lymphoid cells
3. Categorized of wbcs disorder and discuss .
3. Leukocytes
• Blood cells are originate in the
bone marrow.
• To produce different blood cells
at different rates depending on
demand.
• This means we need :
- separate cell lines
- separate colony
stimulating
Factors for each line.
• There are various stem cells
with different abilities to
produce these cell lines .
8. Lymphoid cells
T-cells( “T” for thymus)-
• Produced in bone marrow but
mature in thymus to become :
CD4+/T4 (Helper T-cells)
CD8+/T8 ( cytotoxic T-cells)
(These designations represent
specific proteins on their surface
membranes).
9. B-cells(“B” roughly refers to Bone marrow)-
• Produced and mature in bone marrow.
• Can become plasma cells (plasmocytic) that make
antibodies against specific pathogens .
Natural killer cell-component innate immune system
and kill tumors as well as other dysfunctional cells.
- NK cell work to control viral infections by secreting
IFN γ (interfering gamma )and TNFα(tumor necrosis
factor).
10. WBC’s disorders
• Categorized as :
- Non – Neoplastic:
It May include an increase or a decrease in number of white
blood cells :
Leukopenia, Neutropenia (agranulocytosis) ,infectious
mononucleosis.
-Neoplastic :
a. leukemia
b. lymphoma
c. plasma cell dyscrasia (Multiple myeloma)
11. Non – neoplastic white Blood cell deficiencies
Normal Total WBC count = 4,500-10,500 cells/µl
Leukocytosis:
Leukocytosis refers to an increase in the total number
of white blood cells (WBCs) due to –
-Infection ( bacterial, fungal, viral, protozoan,
parasitic).
-Bone tumor.
-Leukemia.
* it may also occur after strenuous exercise,
convulsions such as epilepsy, emotional stress, pregnancy
and labor, anesthesia, as a side effect of medication (and
epinephrine administration .
12. Neutrophil (polymorphs)
• Morphology-
A polymorphonuclear (PMN) neutrophil commonly
called polymorph or neutrophil .Size – 12-15 um in
diameter. It consist of a characteristic dense
nucleus, having 2-5 lobes and fine purple
cytoplasmic lysosomal granules contain various
enzymes.
- This lysosomal granules are 2 types –
• Primary or azurophilic granules
• Secondary or specific granules
13. • Primary or azurophilic granules –
They are large and coarse and appear early
in the promyelocyte stage. It contain –
a. Hydrolase enzyme.(Biochemical catalyst)
b. Elastase.(proteases break down)
c. Myeloperoxidase. (Degradation enzyme)
d. Microbicidal protein.(microbicide)
14. • Secondary or specific granules –
They are smaller and more numerous . These
appear later at myelocyte stage . It contain –
a. Lactoferrin .(Iron binding protein ;activated
neutrophil sites
b. NADPH oxidase.(Membrane bound protein).
c. Histamine. (Inflammatory response ).
d. Vitamin B12 binding protein .
16. Variations In Count
An increase in neutrophil count (Neutrophil Leucocytosis
or Neutrophilia) or a decrease in count (Neutropenia) may
occur in various diseases.
Neutrophil leucocytosis
Absolute neutrophil count >7,500/cumm
17. The commonest type of leukocytosis and occurs most
commonly as a response to acute bacterial infections.
Some common causes of neutrophilia are as under:-
• Acute infections – ( local/Generalised) especially by
cocci but also by certain bacilli, fungi, spirochaetes,
parasites and some viruses.
• Other inflammations - tissue damage resulting from
burns, operations, ischaemic necrosis (such as in MI),
hypersensitivity reactions etc.
18. Cont…
• Intoxication -Uraemia, Diabetic ketosis, eclampsia,
poisonings by chemicals and drugs.
• Acute haemorrhage, internal or external.
• Acute haemolysis.
• Myeloproliferative disorders
19. Neutropenia
When the absolute neutrophil count falls below
2,500/μl, the patient is said to have neutropenia
and is prone to develop recurrent infections.
Common cause of neutropenia –
• Certain infections e.g. Typhoid, Brucellosis,Influenza,
Measles, Viral hepatitis, Malaria, Kala-azar etc
• Drugs, chemicals and physical agents which induce
Aplasia of the bone marrow cause neutropenia.
20. Cont..
• Certain haematological and other diseases e.g.
Pernicious anaemia, Aplastic anaemia, Cirrhosis of
the liver with splenomegaly.
• Certain hereditary, congenital or familial disorders
e.g.
Cyclic neutropenia, Primary splenic neutropenia,
Idiopathic benign neutropenia.
21. Variations In Morphology
• Granules -Heavy, dark staining, coarse toxic granules
are characteristic of bacterial infections.
• Vacuoles- In bacterial infections such as in
septicaemia, cytoplasmic vacuolation may develop.
• Döhle bodies- These are small, round or oval
patches,2-3 μm in size, in the cytoplasm. They are
mostly seen in bacterial infections.
• Nuclear abnormalities.
22. Defective Functions
• Defective chemotaxis e.g. in a rare congenital abnormality
called lazy-leucocyte syndrome; following corticosteroid
therapy, aspirin ingestion, alcoholism, and in myeloid
leukaemia.
• Defective phagocytosis due to lack of opsonisation e.g.in
hypogammaglobulinaemia, hypocomplementaemia, after
splenectomy,insicklecelldisease.
• Defectivekillinge.g.inchronicgranulomatousdisease,
Chédiak-Higashisyndrome,myeloidleukaemias.
23. Lymphocytes
MORPHOLOGY-
• 20-30 % of all WBCs
• Anatomy
-7-15 μm
- small amount of light blue
cytoplasm.
-coarsly clumped chromatin
. Take the majority of the cell
-nucleas is round –oval in
shape .
24. Pathologic Variations
A rise in the absolute count of lymphocytes
exceeding the upper limit of normal
(above4,000/μm) is termed lymphocytosis, while
absolute lymphocyte count below 1,500/μm is
referred to as lymphopenia.
25. Lymphocytosis
• Absolute count >5.5 x 109/L
• Some of the common causes of
lymphocytosisare as under:
Certain acute infections e.g.
Infectious Mononucleosis, Viral
hepatitis, Infectious lymphocytosis.
Certain chronic infections e.g.
Brucellosis, Tuberculosis,Syphilis.
Haematopoietic disorders e.g.
lymphocytic leukaemias,
lymphoma.
26. Lymphopenia
Lymphopenia is uncommon
and occurs in the following
conditions:
• Most acute infections.
• Severe bone marrow failure.
• Corticosteroid and
immunosuppressive therapy.
27. Monocytes
MORPHOLOGY:-
The monocyte is the largest
mature leucocyte in the
peripheral blood measuring 12-
20 μm in diameter. It possesses a
large, central, oval, notched or
indented or horseshoe-shaped
nucleus which has
characteristically fine reticulated
chromatin network. The
cytoplasm is abundant, pale blue
and contains many fine dust-
like granules and vacuoles.
28. Functions of monocytes are :-
• Phagocytosis of antigenic material or
microorganisms.
• Immunologic function as antigen-presenting cells
and present the antigen to lymphocytes to deal with
further.
• Mediator of inflammation, they are involved in
release of prostaglandins, stimulation of the liver to
secrete acute phase reactants.
29. Pathologic Variations
• A rise in the blood monocytes above 800/μl is termed
monocytosis.
• Some common causes of monocytosis are as follows:
1. Certain bacterial infections e.g. Tuberculosis, Sub acute
bacterial endocarditis, Syphilis.
2. Viral infections.
3. Protozoal aninfections e.g. Malaria, Typhus,
Trypanosomiasis, Kala-azar.
4. Haematopoietic disorders e.g. Monocytic Leukaemia,
Lymphomas, Myeloproliferative Disorders, Multiplemyeloma.
5. Malignancies e.g. Cancer of the Ovary, Stomach, Breast.
6. Granulomatous diseases e.g. Sarcoidosis(abnormal
masses), Inflammatory bowel disease.
30. EOSINOPHIL
MORPHOLOGY
-1-6 % of circulating WBCs .
- They have a bilobed ( spected
shaped )nucleus and the cytoplasm
shows specific orange /red coarse
granules .
These granules are composed of –
a. MBP( major basic protien).
b. peroxidase .
c. lysomal protien.
* immunoglobin E receptors presenent
on their surface play a role in allergic
reactions and killing parasites .
31. Pathologic Variations
Eosinophilia: An increase in the number of
eosinophilic leucocytes above 400/μl is referred to as
eosinophilia and below 40/μl is termed as
eosinopenia.
32. The causes of eosinophilia are as under:
1.Allergic disorders e.g. bronchial asthma, urticaria,
angioneurotic oedema, fever, drug hypersensitivity.
2. Parasitic infestations e.g. trichinosis, echinococcosis,
intestinal parasitism.
3. Skin diseases.
4. Löeffler’s syndrome.
5. Pulmonary infiltration with eosinophilia (PIE)
syndrome.
6. Tropical eosinophilia.
7. Haematopoietic diseases e.g. CML, polycythaemia
vera, pernicious anaemia, Hodgkin’s disease.
33. Eosinopenia.
Adrenal steroids and ACTH induce eosinopeniain
man. Eosinopenia is a form of agranulocytosis where
the number of eosinophil granulocytes is lower than
expected. Leukocytosis with eosinopenia can be a
predictor of bacterial infection. It can be induced by
stress reactions, Cushing's syndrome, or the use
of steroids. Pathological causes include burns and
acute infections.
34. Basophil
MORPHOLOGY
- 0.5-1 % OF ALL WBCs
Anatomy-
-8-10 μm diameter .
-Bilobed or irregular nucleus
-Round, blue-black granules may obscure
nucleus .
Physiology-
-Exit cappilaries to enter tissue fluid .
-Mature into mast cells
. Release heparin, histamine, serotonin
–stimulate inflamtion .
-Hypersensitivity (allergic) reaction.
35. Pathologic Variations
• Basophil leucocytosis or basophilia refers to an
increase in the number of basophilic leucocytes
above 100basophil/μl. Basophilia is unusual and is
found in the following conditions:
1.Chronic myeloid leukaemia
2.Polycythaemia vera
3.Myelosclerosis.(Fibrosis of the bone marrow).
4. Myxedema(severe hypothyroidism).
37. Altered Cell Morphology
• Nuclear variation :
A.Pelger-Huet
B.Hyper segmentation
• Cytoplasmic variation :
A. Alder-Reilly
B. May-Hegglin
C. Vacuolization
D.Dohle Bodies
38. Pelger -Huet disease
•Pelger-Huet anomaly (PHA) is
an inherited blood condition in
which the nuclei of several types
of white blood cells (neutrophils
and eosinophils) have unusual
shape (bilobed, peanut or
dumbbell-shaped instead of the
normal trilobed shape) and
unusual structure (coarse and
lumpy)
• Indicated failure of neutrophil
to segment properley.
39. Hypersegmentation
Neutrophil hypersegmentation can
be defined as the presence
of neutrophils with six or more lobes
or the presence of more than 3%
of neutrophils with at least five lobes.
•The presence of hypersegmented
neutrophils is an important
diagnostic feature of megaloblastic
anaemias and myelodysplastic
syndromes .
40. Alder Anomaly
Alder anomaly is characterized
by large azurophilic granules that
stain dark-purple and are seen
throughout the leukocyte
cytoplasm, even covering the
nucleus. The inclusions (granules)
are seen in the cytoplasm of
almost all mature leukocytes .
• Toxic granulation is seen in
cases of severe infection, as a
result of denatured proteins in
rheumatoid arthritis .
41. Vacuolization
• The presence of vacuolated
polymorphonuclear neutrophils in
blood smears of patients suffering
from infection appears to be
associated with massive bacterial
growth and to constitute a very early
symptom of rapidly life-threatening
septicaemia.
42. Döhle bodies
Döhle bodies(karl Gottfried paul
Döhle) are light blue-gray, oval,
basophilic, leukocyte inclusions located
in the peripheral cytoplasm of
neutrophils. They measure 1-3 μm in
diameter.
• Seen in toxic changes
-Bacterial infection.
-Inflammation.
-Administration of G-CSF.
-During pregenancy .
43. INFECTIOUS MONONUCLEOSIS
Infectious mononucleosis (glandular fever) is an
acute, benign, self-limiting lymphoproliferative
disorders caused by Epstien- Barr-virus(EBV).
Infection may occur from childhood to old age but
the classical acute infection is more common in
teenagers and young adults. The infection is
transmitted by person-to-person contact such as by
kissing with transfer of virally-contaminated saliva.
• Incubation period : it ranges from 4 to 8 weeks .
44. • Type of infection –
- Productive infection : infection seen only in a
minority B cells. The infected B cell produce and
release virions accompanied by death of B cell.
- Latent infection: The virus become latent inside the
B cells . There are no viral replication and the infected
B cells are not killed . These latently infected B cells
are transformed or “immortalized” so they are
capable of prolification identify.
• Immoratalization of B cell is the hallmark of EBV
infection.
45. Clinical features
Incubation period :
adult 30-50 days
children- 15-40 days
• During prodromal period (first 3-
5 days), the symptoms are mild
such as headache and fatigue.
• Frank clinical features (next 7-21
days) commonly are fever, sore
throat and bilateral cervical
lymphadenopathy.
47. Leukaemoid Reactions
• Leukaemoid reaction is defined as a reactive
excessive leukocytosis in the peripheral blood
resembling that of leukaemia in a subject who does
not have leukemia.
48. Myeloid Leukaemoid Reaction
• CAUSES- Majority of leukaemoid reactions involve the
granulocyte series. It may occur in association with a
wide variety of diseases. These are as under:
1. Infections e.g. staphylococcal pneumonia,
disseminated tuberculosis, meningitis, diphtheria,
sepsis, endocarditis,plague, infected abortions etc.
2. Intoxication e.g. eclampsia, mercury poisoning,
severeburns.
3. Malignant diseases e.g. multiple myeloma,
myelofibrosis,Hodgkin’s disease, bone metastases.
4. Severe haemorrhage and severe haemolysis.
49. Lymphoid Leukaemoid Reaction
CAUSES: Lymphoid leukaemoid reaction may be found
in the following conditions:
1. Infections e.g. infectious mononucleosis, pertussis
(whooping cough) caused by Bordetella pertussis,
chickenpox, infectious lymphocytosis, tuberculosis.
2. Malignant diseases may rarely produce lymphoid
leukaemoid reaction.
50. Leukemia
It is a group of malignant disorder, affecting the
blood and blood-forming tissue of the bone marrow
lymph system spleen.
• Cause of leukemia:-
- Congenitel disorder : Down syndrome ,
Immunodeficiency syndrome
- Ionizing radiation : X-ray, Radiotherapy
- Chemicals : Alkelyting agent ,Benzene
- Viruses : Human T-lymphocyte leukemia virus
(HTLV1), EBV.
51. TYPES
• ACCUTE LEUKEMIA:
- Affect younger age group frequently.
- Rapid course and the peripheral blood and bone
marrow show the presence of large number of blast
cells.
- If left untreated ,these are fatal within
weeks/months.
Type-
• Acutel ltmphoblastic eukemia (ALL)
• Acute meylegenous leukemia (AML)
52. • CHORNIC LEUKEMIA :
- Generally affect older people .
- Onset is insidious .
- Usually less aggressive
Type-
• Chornic lymphocytic leukemia (CLL)
• Chornic myelogenus leukemia (CML)
53. Laboratory investigations of ALL
1.CBC
• ↑↑ WBCs with lymphoblasts in the peripheral
blood
• ↓RBCs ( anaemia)
• Plateletes ↓
2. Bone marrow
• Bone marrow aspirate
- All normal elements are depressed and replaced by
abnormal cells.